Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06640465 · ClinicalTrials.gov registry record · Phase 2
Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations
A Phase 2 study, sponsored by OvationLab.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT06640465 is a Phase 2 study that has completed, run by OvationLab. The registered enrollment target is 150 participants.
The verdict
NCT06640465, a Phase 2 study, has completed, sponsored by OvationLab.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations. An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commercially available dietary supplements on increasing CoQ10 concentrations and self-reported health outcomes.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ubiquinol + geranylgeraniol
- DIETARY_SUPPLEMENT Geranylgeraniol
- DIETARY_SUPPLEMENT Ubiquinol
- DIETARY_SUPPLEMENT Ubiquinone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-10-12 |
| Est. Completion | 2025-09-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06640465
The ClinicalTrials.gov registry entry for NCT06640465 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OvationLab, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT06640465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06640465 about?
NCT06640465 is a clinical study titled "Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations". The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations. An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commerc...
What is the current status of trial NCT06640465?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-10-12. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT06640465?
The interventions under investigation include: Placebo (OTHER), Ubiquinol + geranylgeraniol (DIETARY_SUPPLEMENT), Geranylgeraniol (DIETARY_SUPPLEMENT), Ubiquinol (DIETARY_SUPPLEMENT), Ubiquinone (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06640465?
This trial is sponsored by OvationLab, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.